Yesim Dargaud/isth2023
Aug 14, 2025, 13:09
Thrombin Generation Assay to Guide Factor Therapy With Fitusiran
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
“Thrombin Generation Assay to Guide Co‐Administration of Factor Therapies With Fitusiran – I personally think the Thrombin Generation assays could not be used for the clinical management of the patients in non replacement therapies and only show the drug concentration”
Read the full here.
Title: Utilising Thrombin Generation Assay to Guide Co-Administration of Factor Therapies With Fitusiran
Authors: Yesim Dargaud, Christophe Nougier, Stephanie Desage, Hamdi Rezigue, Amy Dericquebourg, Yohann Jourdy, Alexandre Leuci, Anne Lienhart

Discover more on Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD
